SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Beomseok Suh, Sehhoon Park, Dong Wook Shin, Jae Moon Yun, Hyung-Kook Yang, Su Jong Yu, Cheong-Il Shin, Jin-Soo Kim, Eunmi Ahn, Hyejin Lee, Jin Ho Park, BeLong Cho, High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers, Hepatology, 2015, 61, 4
  2. 2
    Fabio Salvatore Macaluso, Marcello Maida, Calogero Cammà, Daniela Cabibi, Nicola Alessi, Giuseppe Cabibbo, Vito Di Marco, Antonio Craxì, Salvatore Petta, Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection, Clinical Gastroenterology and Hepatology, 2014, 12, 5, 878

    CrossRef

  3. 3
    Ye ji Lee, Jeong Min Lee, Jeong Eun Lee, Kyung Bun Lee, Eun Sun Lee, Jeong-Hee Yoon, Mi Hye Yu, Jee Hyun Baek, Cheong Il Shin, Joon Koo Han, Byung Ihn Choi, MR elastography for noninvasive assessment of hepatic fibrosis: Reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement, Journal of Magnetic Resonance Imaging, 2014, 39, 2
  4. 4
    Maurizio Loy, Giancarlo Serra, Luchino Chessa, The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis, Journal of Ultrasound, 2014,

    CrossRef

  5. 5
    Romilda Cardin, Marika Piciocchi, Diego Martines, Laura Scribano, Marino Petracco, Fabio Farinati, Effects of coffee consumption in chronic hepatitis C: A randomized controlled trial, Digestive and Liver Disease, 2013, 45, 6, 499

    CrossRef

  6. 6
    April M. Chow, Mingqian Tan, Darwin S. Gao, Shu Juan Fan, Jerry S. Cheung, Zhongwei Qiao, Kwan Man, Zheng-Rong Lu, Ed X. Wu, Molecular MRI of Liver Fibrosis by a Peptide-Targeted Contrast Agent in an Experimental Mouse Model, Investigative Radiology, 2013, 48, 1, 46

    CrossRef

  7. 7
    Ji Yeon Seo, Won Kim, Jee Hye Kwon, Eun Hyo Jin, Su Jong Yu, Hwi Young Kim, Yong Jin Jung, Donghee Kim, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation, Liver International, 2013, 33, 6
  8. 8
    Sadisu Mohammrd Maàji, Abdulmuminu Yakubu, Daniel Dirioha Odunko, Pattern of abnormal ultrasonographic findings in patients with clinical suspicion of chronic liver disease in Sokoto and its environs, Asian Pacific Journal of Tropical Disease, 2013, 3, 3, 202

    CrossRef

  9. 9
    Jia-You Fang, Tung-Ho Wu, Chun-Hsun Huang, Pei-Wen Wang, Chih-Chieh Chen, Yang-Chang Wu, Tai-Long Pan, Proteomics reveals plasma profiles for monitoring the toxicity caused by chromium compounds, Clinica Chimica Acta, 2013, 423, 23

    CrossRef

  10. 10
    Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Tokihiko Sawada, Survival after surgery for hepatocellular carcinoma in relation to presence or absence of viral infection, The American Journal of Surgery, 2013, 206, 2, 187

    CrossRef

  11. 11
    Juan A. Vílchez, Diana Hernández-Romero, Francisco Marín, The complex role of bone turnover biomarkers in cardiovascular diseases, European Journal of Heart Failure, 2013, 15, 6
  12. 12
    Krystyna Pawlak, Dariusz Rozkiewicz, Michal Mysliwiec, Dariusz Pawlak, YKL-40 in hemodialyzed patients with and without cardiovascular complications – The enhancement by the coexistence of the seropositivity against hepatitis C virus infection, Cytokine, 2013, 62, 1, 75

    CrossRef

  13. 13
    Seyed M. Vaziri-Bozorg, Ahmad R. Ghasemi-Esfe, Omid Khalilzadeh, Mehdi Mazloumi, Mohsen Nassiri-Toosi, Hossein Ghanaati, Hadi Rokni-Yazdi, Diffusion-Weighted Magnetic Resonance Imaging for Diagnosis of Liver Fibrosis and Inflammation in Chronic Viral Hepatitis: The Performance of Low or High b Values and Small or Large Regions of Interest, Canadian Association of Radiologists Journal, 2012, 63, 4, 304

    CrossRef

  14. 14
    April M. Chow, Darwin S. Gao, Shu Juan Fan, Zhongwei Qiao, Frank Y. Lee, Jian Yang, Kwan Man, Ed X. Wu, Liver fibrosis: An intravoxel incoherent motion (IVIM) study, Journal of Magnetic Resonance Imaging, 2012, 36, 1
  15. 15
    April M. Chow, Darwin S. Gao, Shu Juan Fan, Zhongwei Qiao, Frank Y. Lee, Jian Yang, Kwan Man, Ed X. Wu, Measurement of liver T1 and T2 relaxation times in an experimental mouse model of liver fibrosis, Journal of Magnetic Resonance Imaging, 2012, 36, 1
  16. 16
    D. Robert Dufour, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 2012,

    CrossRef

  17. 17
    Sohae Chung, Elodie Breton, Lorenzo Mannelli, Leon Axel, Liver stiffness assessment by tagged MRI of cardiac-induced liver motion, Magnetic Resonance in Medicine, 2011, 65, 4
  18. 18
    Simona Clichici, C. Catoi, T. Mocan, A. Filip, C. Login, A. Nagy, D. Daicoviciu, N. Decea, C. Gherman, R. Moldovan, Adriana Muresan, Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis, Acta Physiologica Hungarica, 2011, 98, 2, 195

    CrossRef

  19. 19
    Éric Bavu, Jean-Luc Gennisson, Mathieu Couade, Jeremy Bercoff, Vincent Mallet, Mathias Fink, Anne Badel, AnaÏs Vallet-Pichard, Bertrand Nalpas, Mickaël Tanter, Stanislas Pol, Noninvasive In Vivo Liver Fibrosis Evaluation Using Supersonic Shear Imaging: A Clinical Study on 113 Hepatitis C Virus Patients, Ultrasound in Medicine & Biology, 2011, 37, 9, 1361

    CrossRef

  20. 20
    Verena Bihrer, Mireen Friedrich-Rust, Bernd Kronenberger, Nicole Forestier, Jörg Haupenthal, Ying Shi, Jan Peveling-Oberhag, Heinfried H Radeke, Christoph Sarrazin, Eva Herrmann, Stefan Zeuzem, Oliver Waidmann, Albrecht Piiper, Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection, The American Journal of Gastroenterology, 2011, 106, 9, 1663

    CrossRef

  21. 21
    Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Tokihiko Sawada, Underweight patients show an increased rate of postoperative death after surgery for hepatocellular carcinoma, Journal of Surgical Oncology, 2011, 104, 7
  22. 22
    A. G. Singal, L. V. Thomassen, D. R. Gretch, M. C. Shuhart, Use of the AST to platelet ratio index in HCV/HIV co-infected patients, Alimentary Pharmacology & Therapeutics, 2011, 33, 5
  23. 23
    Maria Guido, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  24. 24
    Madiha M. El-Attar, Hebat-Allah G. Rashed, Eman M. Sewify, Howayda E. Hassan, A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection, Arab Journal of Gastroenterology, 2010, 11, 4, 206

    CrossRef

  25. 25
    Jerry S. Cheung, Shu Juan Fan, Darwin S. Gao, April M. Chow, Kwan Man, Ed X. Wu, Diffusion tensor imaging of liver fibrosis in an experimental model, Journal of Magnetic Resonance Imaging, 2010, 32, 5
  26. 26
    B. Hermeziu, D. Messous, M. Fabre, M. Munteanu, C. Baussan, O. Bernard, T. Poynard, E. Jacquemin, Evaluation of FibroTest–ActiTest in children with chronic hepatitis C virus infection, Gastroentérologie Clinique et Biologique, 2010, 34, 1, 16

    CrossRef

  27. 27
    Renata Eliane de Ávila, Ricardo Andrade Carmo, Kátia de Paula Farah, Antônio Lúcio Teixeira, Lucas Viana Coimbra, Carlos Maurício de Figueiredo Antunes, José Roberto Lambertucci, Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis, The Brazilian Journal of Infectious Diseases, 2010, 14, 4, 335

    CrossRef

  28. 28
    Martin Krššák, Harald Hofer, Fritz Wrba, Martin Meyerspeer, Attila Brehm, Alfred Lohninger, Petra Steindl-Munda, Ewald Moser, Peter Ferenci, Michael Roden, Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy, European Journal of Radiology, 2010, 74, 3, e60

    CrossRef

  29. 29
    Richard S. Mangus, Michael G. O'Connor, A. Joseph Tector, Joel D. Lim, Rodrigo M. Vianna, Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut, Journal of Pediatric Surgery, 2010, 45, 6, 1266

    CrossRef

  30. 30
    A. Pissaia, D. Borderie, D. Bernard, O. Scatton, Y. Calmus, F. Conti, APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology, Transplantation Proceedings, 2009, 41, 2, 679

    CrossRef

  31. 31
    Susanne Bonekamp, Ihab Kamel, Steven Solga, Jeanne Clark, Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?, Journal of Hepatology, 2009, 50, 1, 17

    CrossRef

  32. 32
    Timothy J.S. Cross, Paolo Rizzi, Philip A. Berry, Matthew Bruce, Bernard Portmann, Phillip M. Harrison, Kingʼs Score: an accurate marker of cirrhosis in chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2009, 21, 7, 730

    CrossRef

  33. 33
    Gamal Shiha, Shiv Kumar Sarin, Alaa Eldin Ibrahim, Masao Omata, Ashish Kumar, Laurentius A. Lesmana, Nancy Leung, Nurdan Tozun, Saeed Hamid, Wasim Jafri, Hitoshi Maruyama, Pierre Bedossa, Massimo Pinzani, Yogesh Chawla, Gamal Esmat, Wahed Doss, Taher Elzanaty, Puja Sakhuja, Ahmed Medhat Nasr, Ashraf Omar, Chun-Tao Wai, Ahmed Abdallah, Mohsen Salama, Abdelkhalek Hamed, Ayman Yousry, Imam Waked, Medhat Elsahar, Amr Fateen, Sherif Mogawer, Hassan Hamdy, Reda Elwakil, Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL), Hepatology International, 2009, 3, 2, 323

    CrossRef

  34. 34
    N. Goyal, N. Jain, V. Rachapalli, D.L. Cochlin, M. Robinson, Non-invasive evaluation of liver cirrhosis using ultrasound, Clinical Radiology, 2009, 64, 11, 1056

    CrossRef

  35. 35
    Ryota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, Eriko Goto, Takahisa Sato, Takamasa Ohki, Jun Imamura, Tadashi Goto, Fumihiko Kanai, Naoya Kato, Hitoshi Ikeda, Shuichiro Shiina, Takao Kawabe, Masao Omata, Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography, Hepatology, 2009, 49, 6
  36. 36
    Frank Lammert, Klaus Ritter, Axel Gressner, Das Laborbuch, 2009,

    CrossRef

  37. 37
    Patrice Cacoub, Fabrice Carrat, Pierre Bédossa, Jérôme Lambert, Guillaume Pénaranda, Christian Perronne, Stanislas Pol, Philippe Halfon, Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study – ANRS HC02, Journal of Hepatology, 2008, 48, 5, 765

    CrossRef

  38. 38
    X. Forns, Diagnosis of liver fibrosis in 2008, Gastroentérologie Clinique et Biologique, 2008, 32, 6, 1

    CrossRef

  39. 39
    Robert J. Fontana, Zachary D. Goodman, Jules L. Dienstag, Herbert L. Bonkovsky, Deepa Naishadham, Richard K. Sterling, Grace L. Su, Mita Ghosh, Elizabeth C. Wright, Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C, Hepatology, 2008, 47, 3
  40. 40
    Rossano Girometti, Alessandro Furlan, Gennaro Esposito, Massimo Bazzocchi, Giuseppe Como, Franca Soldano, Miriam Isola, Pierluigi Toniutto, Chiara Zuiani, Relevance of b-values in evaluating liver fibrosis: A study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences, Journal of Magnetic Resonance Imaging, 2008, 28, 2
  41. 41
    G. T. EVERSON, M. L. SHIFFMAN, T. R. MORGAN, J. C. HOEFS, R. K. STERLING, D. A. WAGNER, C. C. KULIG, T. M. CURTO, E. C. WRIGHT, The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial, Alimentary Pharmacology & Therapeutics, 2008, 27, 9
  42. 42
    Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 5
  43. 43
    Wilma Debernardi-Venon, Silvia Martini, Fiorella Biasi, Barbara Vizio, Angela Termine, Giuseppe Poli, Franco Brunello, Carlo Alessandria, Renato Bonardi, Giorgio Saracco, Mario Rizzetto, Alfredo Marzano, AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers, Journal of Hepatology, 2007, 46, 6, 1026

    CrossRef

  44. 44
    Jaydeep S. Kadam, Andrew H. Talal, Changing Treatment Paradigms: Hepatitis C Virus in HIV-Infected Patients, AIDS Patient Care and STDs, 2007, 21, 3, 154

    CrossRef

  45. 45
    Gamal Esmat, Mohamed Metwally, Khalid R. Zalata, Shahinaz Gadalla, Mohamed Abdel-Hamid, Amr Abouzied, Abdel-Aziz Shaheen, Maissa El-Raziky, Hani Khatab, Sherif El-Kafrawy, Nabiel Mikhail, Laurence S. Magder, Nezam H. Afdhal, G. Thomas Strickland, Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C, Journal of Hepatology, 2007, 46, 4, 620

    CrossRef

  46. 46
    Scott L. Friedman, Don C. Rockey, D. Montgomery Bissell, Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference, Hepatology, 2007, 45, 1
  47. 47
    Damià Parramon, Ivan Erill, Anton Guimerà, Antoni Ivorra, Ángeles Muñoz, Anna Sola, Constantino Fondevila, Juan Carlos García-Valdecasas, Rosa Villa, In vivo detection of liver steatosis in rats based on impedance spectroscopy, Physiological Measurement, 2007, 28, 8, 813

    CrossRef

  48. 48
    Victor de Lédinghen, Brigitte Le Bail, Laurent Rebouissoux, Céline Fournier, Juliette Foucher, Véronique Miette, Laurent Castéra, Laurent Sandrin, Wassil Merrouche, Frédéric Lavrand, Thierry Lamireau, Liver Stiffness Measurement in Children Using FibroScan: Feasibility Study and Comparison With Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and Liver Biopsy, Journal of Pediatric Gastroenterology and Nutrition, 2007, 45, 4, 443

    CrossRef

  49. 49
    Luca Miele, Alessandra Forgione, Giovanni Gasbarrini, Antonio Grieco, Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), Translational Research, 2007, 149, 3, 114

    CrossRef

  50. 50
    Chen–Hua Liu, Shih–Jer Hsu, Jou–Wei Lin, Juey–Jen Hwang, Chun–Jen Liu, Pei–Ming Yang, Ming–Yang Lai, Pei–Jer Chen, Jun–Herng Chen, Jia–Horng Kao, Ding–Shinn Chen, Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index, Clinical Gastroenterology and Hepatology, 2007, 5, 10, 1199

    CrossRef

  51. 51
    G. T. EVERSON, M. A. MARTUCCI, M. L. SHIFFMAN, R. K. STERLING, T. R. MORGAN, J. C. HOEFS, Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt, Alimentary Pharmacology & Therapeutics, 2007, 26, 3
  52. 52
    Leon A. Adams, Paul Angulo, Role of Liver Biopsy and Serum Markers of Liver Fibrosis in Non-alcoholic Fatty Liver Disease, Clinics in Liver Disease, 2007, 11, 1, 25

    CrossRef

  53. 53
    Vicente Lorenzo-Zúñiga, Ramon Bartolí, Helena Masnou, Silvia Montoliu, Rosa M a Morillas, Ramon Planas, Serum Concentrations of Insulin-Like Growth Factor-I (IGF-I) as a Marker of Liver Fibrosis in Patients With Chronic Hepatitis C, Digestive Diseases and Sciences, 2007, 52, 11, 3245

    CrossRef

  54. 54
    Hiroki Ikeda, Michihiro Suzuki, Minoru Kobayashi, Hideaki Takahashi, Nobuyuki Matsumoto, Shiro Maeyama, Shiro Iino, Shigeru Sase, Fumio Itoh, Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C, Hepatology Research, 2007, 37, 2
  55. 55
    Nikolaos V. Chrysanthos, George V. Papatheodoridis, Savvas Savvas, Georgia Kafiri, Kalliopi Petraki, Emanuel K. Manesis, Athanasios J. Archimandritis, Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis, European Journal of Gastroenterology & Hepatology, 2006, 18, 4, 389

    CrossRef

  56. 56
    Adam Gordon, Daryl A Hobbs, D Scott Bowden, Michael J Bailey, Joanne Mitchell, Andrew JP Francis, Stuart K Roberts, Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2006, 21, 1
  57. 57
    Jorge Mendoza, Elena Gómez-Domínguez, Ricardo Moreno-Otero, Elastografía de transición (Fibroscan®), un nuevo método no invasivo en la valoración de la fibrosis hepática, Medicina Clínica, 2006, 126, 6, 220

    CrossRef

  58. 58
    Philippe Halfon, Marc Bourliere, Romaric Deydier, Danielle Botta-Fridlund, Christophe Renou, Albert Tran, Isabelle Portal, Isabelle Allemand, Jean Jacques Bertrand, Alessandra Rosenthal-Allieri, Michel Rotily, Christophe Sattonet, Thierry Benderitter, Marie Christine Saint Paul, Henry Pierre Bonnot, Guillaume Penaranda, Claude Degott, Marie France Masseyeff, Denis Ouzan, Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study, The American Journal of Gastroenterology, 2006, 101, 3, 547

    CrossRef

  59. 59
    L. Huwart, N. Salameh, B.E. Van Beers, L’élastographie du foie, c’est quoi ?, Feuillets de Radiologie, 2006, 46, 3, 211

    CrossRef

  60. 60
    Laurent Huwart, Frank Peeters, Ralph Sinkus, Laurence Annet, Najat Salameh, Leon C. ter Beek, Yves Horsmans, Bernard E. Van Beers, Liver fibrosis: non-invasive assessment with MR elastography, NMR in Biomedicine, 2006, 19, 2
  61. 61
    Robert J. Fontana, David E. Kleiner, Richard Bilonick, Norah Terrault, Nezam Afdhal, Steven H. Belle, Lennox J. Jeffers, Darmendra Ramcharran, Marc G. Ghany, Jay H. Hoofnagle, Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection, Hepatology, 2006, 44, 4
  62. 62
    Ge Zhang, Daniel W. Nebert, Ranajit Chakraborty, Li Jin, Statistical power of association using the extreme discordant phenotype design, Pharmacogenetics and Genomics, 2006, 16, 6, 401

    CrossRef

  63. 63
    Sheng-Nan Lu, Jing-Houng Wang, Shiann-Long Liu, Chao-Hung Hung, Chien-Hung Chen, Hung-Da Tung, Tsung-Ming Chen, Wu-Shiung Huang, Chuan-Mo Lee, Chia-Cheng Chen, Chi-Sin Changchien, Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma, Cancer, 2006, 107, 9
  64. 64
    Maria Alessandra Rosenthal-Allieri, Marie-Line Peritore, Albert Tran, Philippe Halfon, Sylvia Benzaken, Alain Bernard, Analytical variability of the Fibrotest proteins, Clinical Biochemistry, 2005, 38, 5, 473

    CrossRef

  65. 65
    Glenn J Wagner, Gery W Ryan, Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness, AIDS, 2005, 19, Suppl 3, S190

    CrossRef

  66. 66
    Ramón Bataller, David A. Brenner, Liver fibrosis, Journal of Clinical Investigation, 2005, 115, 2, 209

    CrossRef

  67. 67
    Ramón Bataller, David A. Brenner, Liver fibrosis, Journal of Clinical Investigation, 2005, 115, 2, 209

    CrossRef

  68. 68
    Tarik Asselah, Ivan Bièche, Ingrid Laurendeau, Valérie Paradis, Dominique Vidaud, Claude Degott, Michelle Martinot, Pierre Bedossa, Dominique Valla, Michel Vidaud, Patrick Marcellin, Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C, Gastroenterology, 2005, 129, 6, 2064

    CrossRef

  69. 69
    Víctor Vargas, Métodos no invasivos para predecir la fibrosis hepática en la hepatitis por el virus C crónica, Medicina Clínica, 2005, 124, 20, 775

    CrossRef

  70. 70
    Laurent Castéra, Julien Vergniol, Juliette Foucher, Brigitte Le Bail, Elise Chanteloup, Maud Haaser, Monique Darriet, Patrice Couzigou, Victor de Lédinghen, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, 2005, 128, 2, 343

    CrossRef

  71. 71
    Richard K. Sterling, Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection, Clinical Infectious Diseases, 2005, 40, s5, S270

    CrossRef

  72. 72
    Vlad Ratziu, Frédéric Charlotte, Agnès Heurtier, Sophie Gombert, Philippe Giral, Eric Bruckert, André Grimaldi, Frédérique Capron, Thierry Poynard, Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease, Gastroenterology, 2005, 128, 7, 1898

    CrossRef

  73. 73
    Sladjana Pavic, Neda Svirtlih, Jasmina Simonovic, Ivan Boricic, The importance of aminotransferases and platelets count in non-invasive evaluation stages of chronic hepatitis C, Srpski arhiv za celokupno lekarstvo, 2005, 133, 5-6, 262

    CrossRef

  74. 74
    T Nishiura, H Watanabe, M Ito, Y Matsuoka, K Yano, M Daikoku, H Yatsuhashi, K Dohmen, H Ishibashi, Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes, The British Journal of Radiology, 2005, 78, 927, 189

    CrossRef

  75. 75
    Robert J Fontana, Gregory T Everson, Sony Tuteja, Hugo E Vargas, Mitchell L Shiffman, Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis, Clinical Gastroenterology and Hepatology, 2004, 2, 3, 183

    CrossRef

  76. 76
    Doris B. Strader, Teresa Wright, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4
  77. 77
    Jean-Claude Trinchet, Véronique Grando-Lemaire, Diagnostic de cirrhose, Gastroentérologie Clinique et Biologique, 2004, 28, 5, 121

    CrossRef

  78. 78
    Keyur Patel, Stuart C. Gordon, Ira Jacobson, Christophe Hézode, Esther Oh, Katie M. Smith, Jean-Michel Pawlotsky, John G. McHutchison, Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients, Journal of Hepatology, 2004, 41, 6, 935

    CrossRef

  79. 79
    Françoise Imbert-Bismut, Djamila Messous, Vincent Thibaut, Rob B. Myers, Annie Piton, Dominique Thabut, Laure Devers, Bernard Hainque, Anne Mercadier, Thierry Poynard, Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors, Clinical Chemistry and Laboratory Medicine, 2004, 42, 3

    CrossRef

  80. 80
    Philipe Halfon, Denis Ouzan, Laurent Cattan, Patrice Cacoub, Les outils du pronostic de l’infection par le virus de l’hépatite C, La Presse Médicale, 2004, 33, 8, 542

    CrossRef

  81. 81
    Ralf Lichtinghagen, Matthias J Bahr, Noninvasive diagnosis of fibrosis in chronic liver disease, Expert Review of Molecular Diagnostics, 2004, 4, 5, 715

    CrossRef

  82. 82
    Robert J. Fontana, Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond, Gastroenterology Clinics of North America, 2004, 33, 3, 527

    CrossRef

  83. 83
    Xavier Forns, Ramón Bataller, Can we identify liver fibrosis in HCV-infected patients without a liver biopsy?, Current Hepatitis Reports, 2003, 2, 4, 145

    CrossRef

  84. 84
    Pierre Bedossa, Valérie Paradis, Liver extracellular matrix in health and disease, The Journal of Pathology, 2003, 200, 4
  85. 85
    Jules L. Dienstag, The role of liver biopsy in chronic hepatitis C, Hepatology, 2002, 36, S1